A cost-utility analysis of low-dose hormone replacement therapy in postmenopausal women with an intact uterus

ABSTRACT Objective: The objective of this study was to evaluate the cost utility of one year's treatment with a low-dose conjugated estrogen/medroxyprogesterone acetate (CE/MPA low dose) preparation (Premique Low Dose [Wyeth Pharmaceuticals, Maidenhead, UK]), compared with a higher-dose prepara...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Current medical research and opinion 2005-12, Vol.21 (12), p.2051-2061
Hauptverfasser:	Swift, James A., Conway, Peter, Purdie, David W.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cost utility analysis Cost-Benefit Analysis Estrogen Replacement Therapy - economics Estrogens, Conjugated (USP) - administration & dosage Female Hormone replacement therapy Humans Medroxyprogesterone Acetate - administration & dosage Menopause Middle Aged Postmenopause Quality-adjusted life years
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!